Market revenue in 2024 | USD 809.6 million |
Market revenue in 2030 | USD 2,569.5 million |
Growth rate | 21.6% (CAGR from 2025 to 2030) |
Largest segment | Gmp grade |
Fastest growing segment | GMP Grade |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | R&D Grade, GMP Grade |
Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 103.08% in 2024. Horizon Databook has segmented the U.S. plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. held the highest revenue share in North America plasmid DNA manufacturing market owing to the presence of key market players, including CDMOs offering GMP manufacturing services, and the adoption of highly innovative manufacturing technologies for production.
In addition, in 2019, the company launched an internal cGMP plasmid development facility in South San Francisco, which is anticipated to significantly augment an important section of its supply chain, i.e., offer high-quality nonclinical & cGMP-grade plasmids for all its development programs.
Due to the presence of a high number of contract manufacturers and research organizations, the cell & gene therapy manufacturing market space is highly competitive. In addition, the entry of new players coupled with expansion of facilities by existing players has intensified the competition in the U.S. market.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account